{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:46:08Z","timestamp":1774629968323,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072832"],"award-info":[{"award-number":["82072832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) Clinical Capacity Enhancement Project","award":["JSPH-MA-2022-5"],"award-info":[{"award-number":["JSPH-MA-2022-5"]}]},{"name":"Jiangsu Province Capability Improvement Project through Science, Technology and Education","award":["ZDXK202219"],"award-info":[{"award-number":["ZDXK202219"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01595-3","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:29:47Z","timestamp":1740410987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative diagnostic performance of VI-RADS based on biparametric and multiparametric MRI in predicting muscle invasion in bladder cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Peikun","family":"Liu","sequence":"first","affiliation":[]},{"given":"Lingkai","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Linjing","family":"Jiang","sequence":"additional","affiliation":[]},{"given":"Haonan","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Qiang","family":"Cao","sequence":"additional","affiliation":[]},{"given":"Kexin","family":"Bai","sequence":"additional","affiliation":[]},{"given":"Rongjie","family":"Bai","sequence":"additional","affiliation":[]},{"given":"Qikai","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"3","key":"1595_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1595_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","volume":"20","author":"TW Flaig","year":"2022","unstructured":"Flaig TW, et al. NCCN Guidelines(R) insights: bladder Cancer, Version 2.2022. J Natl Compr Canc Netw. 2022;20(8):866\u201378.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1595_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, et al. European Association of Urology Guidelines on non-muscle-invasive bladder Cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"issue":"6","key":"1595_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"M Cumberbatch","year":"2018","unstructured":"Cumberbatch M, et al. Repeat Transurethral Resection in non-muscle-invasive bladder Cancer: a systematic review. Eur Urol. 2018;73(6):925\u201333.","journal-title":"Eur Urol"},{"issue":"7","key":"1595_CR5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1464-410X.2010.09696.x","volume":"107","author":"S Golan","year":"2011","unstructured":"Golan S, et al. Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair - clinical characteristics and oncological outcomes. BJU Int. 2011;107(7):1065\u20138.","journal-title":"BJU Int"},{"issue":"3","key":"1595_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, et al. Multiparametric magnetic resonance imaging for bladder Cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol. 2018;74(3):294\u2013306.","journal-title":"Eur Urol"},{"issue":"3","key":"1595_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/iju.14748","volume":"29","author":"B Yuan","year":"2022","unstructured":"Yuan B, et al. Role of Vesical Imaging-Reporting and Data System in predicting muscle-invasive bladder cancer: a diagnostic meta-analysis. Int J Urol. 2022;29(3):186\u201395.","journal-title":"Int J Urol"},{"issue":"4","key":"1595_CR8","doi-asserted-by":"publisher","first-page":"e070280","DOI":"10.1136\/bmjopen-2022-070280","volume":"13","author":"A Asif","year":"2023","unstructured":"Asif A, et al. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open. 2023;13(4):e070280.","journal-title":"BMJ Open"},{"issue":"11","key":"1595_CR9","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.ejrad.2014.08.012","volume":"83","author":"GX Zhou","year":"2014","unstructured":"Zhou GX, et al. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0 T to assess aggressiveness of bladder cancer. Eur J Radiol. 2014;83(11):2013\u20138.","journal-title":"Eur J Radiol"},{"issue":"4","key":"1595_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.prnil.2019.12.004","volume":"8","author":"J Cho","year":"2020","unstructured":"Cho J, et al. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group. Prostate Int. 2020;8(4):146\u201351.","journal-title":"Prostate Int"},{"issue":"1","key":"1595_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40644-023-00632-0","volume":"23","author":"S Woo","year":"2023","unstructured":"Woo S, et al. Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI. Cancer Imaging. 2023;23(1):110.","journal-title":"Cancer Imaging"},{"issue":"6","key":"1595_CR12","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1007\/s00330-020-07473-6","volume":"31","author":"PA Delli","year":"2021","unstructured":"Delli PA, et al. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach. Eur Radiol. 2021;31(6):3874\u201383.","journal-title":"Eur Radiol"},{"issue":"1","key":"1595_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40644-022-00459-1","volume":"22","author":"T Bricio","year":"2022","unstructured":"Bricio T, et al. What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis. Cancer Imaging. 2022;22(1):20.","journal-title":"Cancer Imaging"},{"issue":"11","key":"1595_CR14","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1007\/s00330-022-08813-4","volume":"32","author":"M Watanabe","year":"2022","unstructured":"Watanabe M, et al. Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field. Eur Radiol. 2022;32(11):7513\u201321.","journal-title":"Eur Radiol"},{"issue":"1","key":"1595_CR15","doi-asserted-by":"publisher","first-page":"20689","DOI":"10.1038\/s41598-022-19273-7","volume":"12","author":"TI Noh","year":"2022","unstructured":"Noh TI, et al. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS. Sci Rep. 2022;12(1):20689.","journal-title":"Sci Rep"},{"key":"1595_CR16","doi-asserted-by":"publisher","first-page":"110282","DOI":"10.1016\/j.ejrad.2022.110282","volume":"151","author":"A Elshetry","year":"2022","unstructured":"Elshetry A, et al. Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer. Eur J Radiol. 2022;151:110282.","journal-title":"Eur J Radiol"},{"issue":"2","key":"1595_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s00330-021-08203-2","volume":"32","author":"C Feng","year":"2022","unstructured":"Feng C, et al. Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma. Eur Radiol. 2022;32(2):890\u2013900.","journal-title":"Eur Radiol"},{"key":"1595_CR18","unstructured":"Moch H, Lyon et al. France: International Agency for Research on Cancer; 2016."},{"key":"1595_CR19","first-page":"263","volume-title":"International Union Against Cancer TNM classification of malignant tumors","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, et al. International Union Against Cancer TNM classification of malignant tumors. Volume 8. New York, NY: Wiley-Blackwell; 2017. p. 263."},{"issue":"9","key":"1595_CR20","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1007\/s00330-022-08696-5","volume":"32","author":"L Ye","year":"2022","unstructured":"Ye L, et al. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Radiol. 2022;32(9):6480\u201392.","journal-title":"Eur Radiol"},{"issue":"1","key":"1595_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2214\/ajr.184.1.01840121","volume":"184","author":"A Tekes","year":"2005","unstructured":"Tekes A, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2005;184(1):121\u20137.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1595_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1148\/radiol.2019182506","volume":"291","author":"H Wang","year":"2019","unstructured":"Wang H, et al. Multiparametric MRI for bladder Cancer: validation of VI-RADS for the detection of Detrusor muscle Invasion. Radiology. 2019;291(3):668\u201374.","journal-title":"Radiology"},{"issue":"1","key":"1595_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1148\/radiology.187.1.8451403","volume":"187","author":"Y Narumi","year":"1993","unstructured":"Narumi Y, et al. Bladder wall morphology: in vitro MR imaging-histopathologic correlation. Radiology. 1993;187(1):151\u20135.","journal-title":"Radiology"},{"issue":"1","key":"1595_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00261-013-0038-0","volume":"39","author":"HJ Wang","year":"2014","unstructured":"Wang HJ, et al. Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. Abdom Imaging. 2014;39(1):135\u201341.","journal-title":"Abdom Imaging"},{"issue":"2","key":"1595_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","volume":"47","author":"S Aslan","year":"2022","unstructured":"Aslan S, et al. Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion? Abdom Radiol (NY). 2022;47(2):771\u201380.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"1595_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmri.27361","volume":"55","author":"V Panebianco","year":"2022","unstructured":"Panebianco V, et al. VI-RADS for bladder Cancer: current applications and future developments. J Magn Reson Imaging. 2022;55(1):23\u201336.","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"1595_CR27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/jmri.24663","volume":"41","author":"HT Nguyen","year":"2015","unstructured":"Nguyen HT, et al. Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters. J Magn Reson Imaging. 2015;41(5):1374\u201382.","journal-title":"J Magn Reson Imaging"},{"key":"1595_CR28","doi-asserted-by":"publisher","first-page":"110587","DOI":"10.1016\/j.ejrad.2022.110587","volume":"157","author":"X Yang","year":"2022","unstructured":"Yang X, et al. Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer. Eur J Radiol. 2022;157:110587.","journal-title":"Eur J Radiol"},{"issue":"1","key":"1595_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1148\/radiol.2511080873","volume":"251","author":"M Takeuchi","year":"2009","unstructured":"Takeuchi M, et al. Urinary bladder cancer: diffusion-weighted MR imaging\u2013accuracy for diagnosing T stage and estimating histologic grade. Radiology. 2009;251(1):112\u201321.","journal-title":"Radiology"},{"issue":"9","key":"1595_CR30","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1007\/s00330-017-4758-3","volume":"27","author":"V Panebianco","year":"2017","unstructured":"Panebianco V, et al. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. Eur Radiol. 2017;27(9):3759\u201366.","journal-title":"Eur Radiol"},{"issue":"10","key":"1595_CR31","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1007\/s00261-023-03979-x","volume":"48","author":"U Eryuruk","year":"2023","unstructured":"Eryuruk U, Tasdemir MN, Aslan S. Comparison of the diagnostic performance of biparametric and multiparametric MRI in detecting muscle invasion of bladder cancer located at the ureteral orifice. Abdom Radiol (NY). 2023;48(10):3174\u201382.","journal-title":"Abdom Radiol (NY)"},{"key":"1595_CR32","doi-asserted-by":"crossref","unstructured":"Arita Y, Kwee TC, Woo S, et al. Biparametric versus multiparametric magnetic resonance imaging for assessing muscle invasion in bladder urothelial carcinoma with variant histology using the Vesical Imaging-Reporting and Data System[J]. Eur Urol Focus; 2023.","DOI":"10.1016\/j.euf.2023.08.004"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01595-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01595-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01595-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:29:56Z","timestamp":1740410996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01595-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01595-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, the Ethics Committee of Jiangsu Provincial People\u2019s Hospital (IRB) reviewed the study\u2019s design and determined that ethical approval was not required due to its retrospective nature. Consequently, the committee waived the need for formal ethics approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate"}},{"value":"Informed consent was obtained from each participant through verbal meetings or telephone follow-up.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}